X Square Capital, LLC Incyte Corp Transaction History

X Square Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $397,456 - $583,646	-5,358 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $7,304 - $9,572	100 Added 1.9%	5,358 $468,000
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $6,335 - $7,527	-87 Reduced 1.63%	5,258 $390,000
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $4,807 - $6,634	-79 Reduced 1.46%	5,345 $358,000
Q1 2018 May 11, 2018	BUY	$83.06 - $100.98 $450,517 - $547,715	5,424 New	5,424 $452,000

629

198M

766K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $14.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on X Square Capital, LLC with notifications on news.